Management of Malignant Pleural Effusions in US Veterans: A Retrospective Review

被引:1
|
作者
Mohs, Zachary [1 ]
DeVillers, Megan [1 ]
Ziegler, Stephanie [1 ]
Basson, Marc D. [2 ,4 ]
Newman, William [1 ,3 ]
机构
[1] UND, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND USA
[2] UND, Sch Med & Hlth Sci, Dept Surg, Grand Forks, ND USA
[3] Fargo Vet Affairs Med Ctr, Dept Internal Med, Fargo, ND USA
[4] UND, Sch Med & Hlth Sci, Dept Surg, 1301 N Columbia Rd, Grand Forks, ND 58203 USA
关键词
talc pleurodesis; indwelling pleural catheter; malignant pleural effusion; TALC PLEURODESIS; CATHETER; DYSPNEA;
D O I
10.5761/atcs.oa.22-00124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare malignant pleural effusion (MPE) treatment outcomes and compli-cations among patients receiving indwelling pleural catheter (IPC), talc pleurodesis (TPS), or dual therapy. Outcomes were determined by measuring length of stay (LOS) and post-procedure dyspnea scores. Complications were measured by comparing intervention failures and adverse events.Methods: The Veterans Affairs' Corporate Data Warehouse was utilized to retrospectively review the charts of 314 MPE subjects. Dyspnea scores were estimated by researchers and LOS was determined by adding the duration of stay for all admissions post procedure. Complications were recorded through chart review.Results: IPC exhibited higher failure rates than the other approaches 1 year post inter-vention. Pneumonia/chest infection rate and lung entrapment were also more prevalent. There was no significant difference in dyspnea rates. LOS illustrated a significant differ-ence between groups, with talc patients spending a median of 7 days in the hospital immediately post procedure, while IPC and IPC + TPS patients spent a median of 3 and 2 days, respectively.Conclusion: Patients receiving IPC or combination treatment spend fewer days in the hospital than TPS patients. However, IPC appears to be associated with more adverse events and higher long-term failure rates than other management strategies.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [31] INTERVENTIONS FOR THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    Clive, A. O.
    Jones, H. E.
    Bhatnagar, R.
    Preston, N. J.
    Maskell, N. A.
    THORAX, 2015, 70 : A15 - A15
  • [32] THORACOSCOPIC MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    COLT, HG
    CLINICS IN CHEST MEDICINE, 1995, 16 (03) : 505 - &
  • [33] The management of malignant pleural and pericardial effusions
    Fiocco, M
    Krasna, MJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (02) : 253 - &
  • [34] Management of Septated Malignant Pleural Effusions
    Banka, Radhika
    Terrington, Dayle
    Mishra, Eleanor K.
    CURRENT PULMONOLOGY REPORTS, 2018, 7 (01) : 1 - 5
  • [35] Malignant Pleural Effusions—Personalised Management
    Ahmed M.
    Wrightson J.M.
    Current Geriatrics Reports, 2018, 7 (3) : 154 - 159
  • [36] DIAGNOSIS AND MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    FENTON, KN
    RICHARDSON, JD
    AMERICAN JOURNAL OF SURGERY, 1995, 170 (01): : 69 - 74
  • [37] Outpatient management of malignant pleural effusions
    Bertolaccini, L
    Zamprogna, C
    D'Urso, A
    Barberis, L
    Manno, E
    Massaglia, F
    LUNG CANCER, 2005, 49 : S331 - S331
  • [38] Pleural procedures in the management of malignant effusions
    Ferreiro, Lucia
    Suarez-Antelo, Juan
    Valdes, Luis
    ANNALS OF THORACIC MEDICINE, 2017, 12 (01) : 3 - 10
  • [39] Management of Septated Malignant Pleural Effusions
    Radhika Banka
    Dayle Terrington
    Eleanor K. Mishra
    Current Pulmonology Reports, 2018, 7 (1) : 1 - 5
  • [40] Thoracoscopic management of malignant pleural effusions
    Yim, APC
    Chung, SS
    Lee, TW
    Lam, CK
    Ho, JKS
    CHEST, 1996, 109 (05) : 1234 - 1238